Implantable Cardioverter-Defibrillator Therapy in Pediatric Patients and Congenital Heart Disease

Cardiac Electrophysiology Clinics

Volumn 3, Issue 3, 2011, Pages 349-357

  Hill, Allison C ^a   Dubin, Anne M ^a,b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Congenital heart disease; Implantable cardioverter defibrillator; Pediatric; Sudden cardiac death

Indexed keywords

CARDIAC PATIENT; CHILD GROWTH; CONGENITAL HEART DISEASE; DEFIBRILLATOR; DEVICE SAFETY; ELECTROPHYSIOLOGY; FALLOT TETRALOGY; HEART ATRIUM ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE PERFORATION; HEMATOMA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; PEDIATRIC CARDIOLOGY; PNEUMOTHORAX; PRIORITY JOURNAL; PULSE GENERATOR; QUALITY OF LIFE; REVIEW; SINUS TACHYCARDIA; STRANGULATION; STROKE; SUDDEN DEATH; TREATMENT FAILURE; TRICUSPID VALVE REGURGITATION; VEIN THROMBOSIS;

EID: 80052275111     PISSN: 18779182     EISSN: 18779190     Source Type: Journal    
DOI: 10.1016/j.ccep.2011.05.002     Document Type: Review

References (78)

1. Maron B.J., Doerer J.J., Haas T.S., et al. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation 2009, 119(8):1085-1092.
2. Liberthson R.R. Sudden death from cardiac causes in children and young adults. N Engl J Med 1996, 334(16):1039-1044.
3. Silka M.J., Hardy B.G., Menashe V.D., et al. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 1998, 32(1):245-251.
4. Oechslin E.N., Harrison D.A., Connelly M.S., et al. Mode of death in adults with congenital heart disease. Am J Cardiol 2000, 86(10):1111-1116.
5. Nadkarni V.M., Larkin G.L., Peberdy M.A., et al. First documented rhythm and clinical outcome from in-hospital cardiac arrest among children and adults. JAMA 2006, 295(1):50-57.
6. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997, 337(22):1576-1583.
7. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346(12):877-883.
8. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005, 352(3):225-237.
9. Burns K.M., Evans F., Kaltman J. Pediatric ICD Utilization in the United States from 1997-2006. Heart Rhythm 2010, Available at:, Accessed October 24, 2010. http://www.ncbi.nlm.nih.gov.laneproxy.stanford.edu/pubmed/20887811.
10. Epstein A.E., DiMarco J.P., Ellenbogen K.A., et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008, 117(21):e350-e408.
11. Gregoratos G., Abrams J., Epstein A.E., et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol 2002, 40(9):1703-1719.
12. Berul C.I., Van Hare G.F., Kertesz N.J., et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 2008, 51(17):1685-1691.
13. Maron B.J. Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Cardiol Rev 2002, 10(3):173-181.
14. Maron B.J., Shen W.K., Link M.S., et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000, 342(6):365-373.
15. Maron B.J., Spirito P., Shen W., et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 2007, 298(4):405-412.
16. Begley D.A., Mohiddin S.A., Tripodi D., et al. Efficacy of implantable cardioverter-defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 2003, 26(9):1887-1896.
17. Zareba W., Moss A.J., Schwartz P.J., et al. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med 1998, 339(14):960-965.
18. Friedman R.A., Van Zandt H., Collins E., et al. Lead extraction in young patients with and without congenital heart disease using the subclavian approach. Pacing Clin Electrophysiol 1996, 19(5):778-783.
19. Zareba W., Moss A.J., Daubert J.P., et al. Implantable cardioverter-defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol 2003, 14(4):337-341.
20. Alexander M.E., Walsh E.P., Saul J.P., et al. Value of programmed ventricular stimulation in patients with congenital heart disease. J Cardiovasc Electrophysiol 1999, 10(8):1033-1044.
21. Nollert G.D., Däbritz S.H., Schmoeckel M., et al. Risk factors for sudden death after repair of tetralogy of Fallot. Ann Thorac Surg 2003, 76(6):1901-1905.
22. Chatrath R., Porter C.J., Ackerman M.J. Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults. Mayo Clin Proc 2002, 77(3):226-231.
23. Stefanelli C.B., Bradley D.J., Leroy S., et al. Implantable cardioverter-defibrillator therapy for life-threatening arrhythmias in young patients. J Interv Card Electrophysiol 2002, 6(3):235-244.
24. Wilson W.R., Greer G.E., Grubb B.P. Implantable cardioverter-defibrillators in children: a single-institutional experience. Ann Thorac Surg 1998, 65(3):775-778.
25. Link M.S., Hill S.L., Cliff D.L., et al. Comparison of frequency of complications of implantable cardioverter-defibrillators in children versus adults. Am J Cardiol 1999, 83(2):263-266.
26. Sherrid M.V., Daubert J.P. Risks and challenges of implantable cardioverter-defibrillators in young adults. Prog Cardiovasc Dis 2008, 51(3):237-263.
27. Bracke F., Meijer A., Van Gelder B. Extraction of pacemaker and implantable cardioverter defibrillator leads: patient and lead characteristics in relation to the requirement of extraction tools. Pacing Clin Electrophysiol 2002, 25(7):1037-1040.
28. Cooper J.M., Stephenson E.A., Berul C.I., et al. Implantable cardioverter-defibrillator lead complications and laser extraction in children and young adults with congenital heart disease: implications for implantation and management. J Cardiovasc Electrophysiol 2003, 14(4):344-349.
29. Saad E.B., Saliba W.I., Schweikert R.A., et al. Nonthoracotomy implantable defibrillator lead extraction: results and comparison with extraction of pacemaker leads. Pacing Clin Electrophysiol 2003, 26(10):1944-1950.
30. Epstein L.M., Byrd C.L., Wilkoff B.L., et al. Initial experience with larger laser sheaths for the removal of transvenous pacemaker and implantable defibrillator leads. Circulation 1999, 100(5):516-525.
31. Alexander M.E., Cecchin F., Walsh E.P., et al. Implications of implantable cardioverter-defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol 2004, 15(1):72-76.
32. Rinaldi C.A., Simon R.D., Baszko A., et al. A 17-year experience of inappropriate shock therapy in patients with implantable cardioverter-defibrillators: are we getting any better?. Heart 2004, 90(3):330-331.
33. Love B.A., Barrett K.S., Alexander M.E., et al. Supraventricular arrhythmias in children and young adults with implantable cardioverter-defibrillators. J Cardiovasc Electrophysiol 2001, 12(10):1097-1101.
34. Korte T., Köditz H., Niehaus M., et al. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter-defibrillator. Pacing Clin Electrophysiol 2004, 27(7):924-932.
35. Goel A.K., Berger S., Pelech A., et al. Implantable cardioverter-defibrillator therapy in children with long QT syndrome. Pediatr Cardiol 2004, 25(4):370-378.
36. Botsch M.P., Franzbach B., Opgen-Rhein B., et al. ICD therapy in children and young adults: low incidence of inappropriate shock delivery. Pacing Clin Electrophysiol 2010, 33(6):734-741.
37. Werner B., Przybylski A., Kucińska B., et al. Implantable cardioverter-defibrillators in children. Kardiol Pol 2004, 60(3):239-246.
38. Eicken A., Kolb C., Lange S., et al. Implantable cardioverter-defibrillator (ICD) in children. Int J Cardiol 2006, 107(1):30-35.
39. Pablo Kaski J., Tomé Esteban M.T., Lowe M., et al. Outcomes after implantable cardioverter-defibrillator treatment in children with hypertrophic cardiomyopathy. Heart 2007, 93(3):372-374.
40. Celiker A., Olgun H., Karagoz T., et al. Midterm experience with implantable cardioverter-defibrillators in children and young adults. Europace 2010, 12(12):1732-1738.
41. Heersche J.H.M., Blom N.A., van de Heuvel F., et al. Implantable cardioverter-defibrillator therapy for prevention of sudden cardiac death in children in the Netherlands. Pacing Clin Electrophysiol 2010, 33(2):179-185.
42. Silka M.J., Kron J., Dunnigan A., et al. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society. Circulation 1993, 87(3):800-807.
43. Kistler P.M., Fynn S.P., Mond H.G., et al. The subpectoral pacemaker implant: it isn't what it seems!. Pacing Clin Electrophysiol 2004, 27(3):361-364.
44. Lee J.C.R., Shannon K., Boyle N.G., et al. Evaluation of safety and efficacy of pacemaker and defibrillator implantation by axillary incision in pediatric patients. Pacing Clin Electrophysiol 2004, 27(3):304-307.
45. Gold M.R., Peters R.W., Johnson J.W., et al. Complications associated with pectoral cardioverter-defibrillator implantation: comparison of subcutaneous and submuscular approaches. Worldwide Jewel Investigators. J Am Coll Cardiol 1996, 28(5):1278-1282.
46. Trappe H.J. The modern implantable cardioverter-defibrillator: comparing it to those of the late 1980s. Am J Cardiol 1996, 78(5A):3-8.
47. Chevalier P., Moncada E., Canu G., et al. Symptomatic pericardial disease associated with patch electrodes of the automatic implantable cardioverter-defibrillator: an underestimated complication?. Pacing Clin Electrophysiol 1996, 19:2150-2152.
48. Berul C.I., Triedman J.K., Forbess J., et al. Minimally invasive cardioverter-defibrillator implantation for children: an animal model and pediatric case report. Pacing Clin Electrophysiol 2001, 24(12):1789-1794.
49. Stephenson E.A., Batra A.S., Knilans T.K., et al. A multicenter experience with novel implantable cardioverter-defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol 2006, 17(1):41-46.
50. Cannon B.C., Friedman R.A., Fenrich A.L., et al. Innovative techniques for placement of implantable cardioverter-defibrillator leads in patients with limited venous access to the heart. Pacing Clin Electrophysiol 2006, 29(2):181-187.
51. Tomaske M., Prêtre R., Rahn M., et al. Epicardial and pleural lead ICD systems in children and adolescents maintain functionality over 5 years. Europace 2008, 10(10):1152-1156.
52. Hsia T., Bradley S.M., LaPage M.J., et al. Novel minimally invasive, intrapericardial implantable cardioverter-defibrillator coil system: a useful approach to arrhythmia therapy in children. Ann Thorac Surg 2009, 87(4):1234-1238. [discussion 1238-39].
53. Kaltman J.R., Gaynor J.W., Rhodes L.A., et al. Subcutaneous array with active can implantable cardioverter-defibrillator configuration: a follow-up study. Congenit Heart Dis 2007, 2(2):125-129.
54. Kriebel T., Ruschewski W., Gonzalez y Gonzalez M., et al. ICD Implantation in infants and small children: the extracardiac technique. Pacing Clin Electrophysiol 2006, 29(12):1319-1325.
55. Gradaus R., Hammel D., Kotthoff S., et al. Nonthoracotomy implantable cardioverter-defibrillator placement in children: use of subcutaneous array leads and abdominally placed implantable cardioverter defibrillators in children. J Cardiovasc Electrophysiol 2001, 12(3):356-360.
56. Luedemann M., Hund K., Stertmann W., et al. Implantable cardioverter defibrillator in a child using a single subcutaneous array lead and an abdominal active can. Pacing Clin Electrophysiol 2004, 27(1):117-119.
57. Madan N., Gaynor J.W., Tanel R., et al. Single-finger subcutaneous defibrillation lead and active can: a novel minimally invasive defibrillation configuration for implantable cardioverter-defibrillator implantation in a young child. J Thorac Cardiovasc Surg 2003, 126(5):1657-1659.
58. Watanabe H., Hayashi J., Haga M., et al. Successful implantation of a cardioverter-defibrillator in an infant. Ann Thorac Surg 2001, 72(6):2125-2127.
59. Greene A.E., Berger J.T., Heshmat Y., et al. Transcutaneous implantation of an internal cardioverter-defibrillator in a small infant with recurrent myocardial ischemia and cardiac arrest simulating sudden infant death syndrome. Pacing Clin Electrophysiol 2004, 27(1):112-116.
60. McLeod K.A., McLean A. Implantation of a fully subcutaneous ICD in Children. Pacing Clin Electrophysiol 2010, [Epub ahead of print].
61. Radbill A.E., Triedman J.K., Berul C.I., et al. System survival of nontransvenous implantable cardioverter-defibrillators compared to transvenous implantable cardioverter-defibrillators in pediatric and congenital heart disease patients. Heart Rhythm 2010, 7(2):193-198.
62. Lawrence D., Von Bergen N., Law I.H., et al. Inappropriate ICD discharges in single-chamber versus dual-chamber devices in the pediatric and young adult population. J Cardiovasc Electrophysiol 2009, 20(3):287-290.
63. Wilkoff B.L., Kühlkamp V., Volosin K., et al. Critical analysis of dual-chamber implantable cardioverter-defibrillator arrhythmia detection: results and technical considerations. Circulation 2001, 103(3):381-386.
64. Lickfett L., Bitzen A., Arepally A., et al. Incidence of venous obstruction following insertion of an implantable cardioverter-defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement. Europace 2004, 6(1):25-31.
65. Sticherling C., Chough S.P., Baker R.L., et al. Prevalence of central venous occlusion in patients with chronic defibrillator leads. Am Heart J 2001, 141(5):813-816.
66. Cecchin F., Atallah J., Walsh E.P., et al. Lead extraction in pediatric and congenital heart disease patients. Circ Arrhythm Electrophysiol 2010, 3(5):437-444.
67. Gasparini M., Mantica M., Galimberti P., et al. Inferior vena cava loop of the implantable cardioverter-defibrillator endocardial lead: a possible solution of the growth problem in pediatric implantation. Pacing Clin Electrophysiol 2000, 23(12):2108-2112.
68. Antretter H., Hangler H., Colvin J., et al. Inferior vena caval loop of an endocardial pacing lead did not solve the growth problem in a child. Pacing Clin Electrophysiol 2001, 24(11):1706-1708. [discussion: 1709].
69. Stojanov P., Velimirović D., Hrnjak V., et al. Absorbable suture technique: solution to the growth problem in pediatric pacing with endocardial leads. Pacing Clin Electrophysiol 1998, 21:65-68.
70. Dubin A.M., Batsford W.P., Lewis R.J., et al. Quality-of-life in patients receiving implantable cardioverter-defibrillators at or before age 40. Pacing Clin Electrophysiol 1996, 19:1555-1559.
71. Sears S.F., Conti J.B. Implantable cardioverter-defibrillators for children and young adolescents: mortality benefit confirmed-what's next?. Heart 2004, 90(3):241-242.
72. Sears S.F., Burns J.L., Handberg E., et al. Young at heart: understanding the unique psychosocial adjustment of young implantable cardioverter-defibrillator recipients. Pacing Clin Electrophysiol 2001, 24(7):1113-1117.
73. Sears S.F., St Amant J.B., Zeigler V. Psychosocial considerations for children and young adolescents with implantable cardioverter-defibrillators: an update. Pacing Clin Electrophysiol 2009, 32(Suppl 2):S80-S82.
74. DeMaso D.R., Lauretti A., Spieth L., et al. Psychosocial factors and quality of life in children and adolescents with implantable cardioverter-defibrillators. Am J Cardiol 2004, 93(5):582-587.
75. Hammill S.C., Kremers M.S., Stevenson L.W., et al. Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm 2010, 7(9):1340-1345.
76. Swerdlow C.D., Gunderson B.D., Ousdigian K.T., et al. Downloadable software algorithm reduces inappropriate shocks caused by implantable cardioverter-defibrillator lead fractures: a prospective study. Circulation 2010, 122(15):1449-1455.
77. Jolley M., Stinstra J., Pieper S., et al. A computer modeling tool for comparing novel ICD electrode orientations in children and adults. Heart Rhythm 2008, 5(4):565-572.
78. Vadakkumpadan F., Rantner L.J., Tice B., et al. Image-based models of cardiac structure with applications in arrhythmia and defibrillation studies. J Electrocardiol 2009, 42(2). 157, e1-10.